Global Herpes Simplex Partnering (2012-2018) Deals Listed by Company, Industry Sector, Stage of Development, and Technology Type - ResearchAndMarkets.com

DUBLIN--()--The "Global Herpes simplex Partnering 2012 to 2018" report has been added to ResearchAndMarkets.com's offering.

The report provides understanding and access to the partnering deals and agreements entered into by the world's leading healthcare companies.

The report provides an analysis of partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.

Report Scope:

  • Trends in partnering deals
  • Top deals by value
  • Deals listed by company A-Z, industry sector, stage of development, technology type

Key Topics Covered:

Executive Summary

Chapter 1 - Therapy partnering trends in numbers

Partnering in numbers - by year
Partnering in numbers - most active
Partnering in numbers - by industry sector
Partnering in numbers - by deal type
Partnering in numbers - by technology type
Partnering in numbers - by stage of development

Chapter 2 - Most active dealmakers

Chapter 3 - Partnering deals directory

Partnering deals directory - by company A-Z
Partnering deals directory - by deal value
Partnering deals directory - by industry sector
Partnering deals directory - by deal type
Partnering deals directory - by stage of development
Partnering deals directory - by technology area

Chapter 4 - Partnering deals with a contract document

Chapter 5 - M&A in numbers

M&A in numbers - by year

Chapter 6 - M&A deals directory

M&A deals directory - by company A-Z
M&A deals directory - by deal value

Chapter 7 - Financing in numbers

Financing in numbers - by year
Financing in numbers - by financing type

Chapter 8 - Financing deals directory

Financing deals directory - by company A-Z
Financing deals directory - by deal value
Financing deals directory - by financing type

For more information about this report visit https://www.researchandmarkets.com/research/p8cg3l/global_herpes?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Infectious Diseases Drugs

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Infectious Diseases Drugs